4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-009890
CFO and Treasurer sold 1,448 shares at an average $74.68 ($108,135)
- CFO and Treasurer acquired 4,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. CFO and Treasurer | 2021-02-07 | Option exercise | +4,250 | 14,427 | D | ||
| Krognes Steve E. CFO and Treasurer | 2021-02-09 | Sale | −1,022 | $74.38 | $76,018 | 13,405 | D |
| Krognes Steve E. CFO and Treasurer | 2021-02-09 | Sale | −426 | $75.39 | $32,116 | 12,979 | D |
| Derivatives | |||||||
| Krognes Steve E. CFO and Treasurer | 2021-02-07 | Option exercise · Restricted Stock Units | −4,250 | 8,500 | D | ||
| Open-market sales · 1,448 sh · avg $74.68 · $108,135 | |||||||
Loading xslF345X03/doc4.xml…